GGrantIndex
Sort

64,565 grants matching drug discovery

Systematic Alzheimer's disease drug repositioning (SMART) based on bioinformatics-guided phenotype screening and image-omics

$689,643
Stephen Tc Wong · Methodist Hospital Research Institute · R01 · FY2019 · AG

Small molecule biased agonists of the NPS receptor

$689,627
Scott P Runyon · Research Triangle Institute · R56 · FY2017 · MH

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Harvard Medical School · R01 · FY2013 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA

Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions

$689,571
Li Zhou · Brigham And Women'S Hospital · R01 · FY2019 · AI

Development of Fluorescent False Neurotransmitters

$689,530
Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2020 · MH

Knowledge Management Center for Illuminating the Druggable Genome

$689,480
Dac-Trung Nguyen · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR

Genetic Analysis of Attention Deficit Hyperactivity Disorder

$689,463
Maximilian Muenke · National Human Genome Research Institute · ZIA · FY2014 · HG

Controlling the flux of sphingosine-1-phosphate in vivo

$689,462
Kevin R Lynch · University Of Virginia · R01 · FY2021 · AI

Controlling the flux of sphingosine-1-phosphate in vivo

$689,462
Kevin R Lynch · University Of Virginia · R01 · FY2022 · AI

Controlling the flux of sphingosine-1-phosphate in vivo

$689,462
Kevin R Lynch · University Of Virginia · R01 · FY2023 · AI

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2022 · AI

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2024 · AI

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2023 · AI

Qualification of Prognostic and Diagnostic Biomarkers of Knee Osteoarthritis

$689,367
Virginia B. Kraus · Duke University · R01 · FY2017 · AR

Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy

$689,330
Yu Leo Lei · University Of Michigan At Ann Arbor · U01 · FY2023 · DE

Drug Discovery for Human African Trypanosomiasis

$689,303
Michael H Gelb · University Of Washington · R01 · FY2013 · AI

Schizophrenia interactome mapping and global discovery of brain splice variants

$689,159
Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2011 · MH

Scalable Synthesis and New Bond Disconnections

$689,102
Phil S Baran · Scripps Research Institute, The · R35 · FY2016 · GM

Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma

$688,755
Esteban Gonzalez Burchard · University Of California, San Francisco · R01 · FY2016 · HL

Ultrahigh-throughput Identification of Molecular Targets of Natural Products

$688,748
Daojing Wang · Newomics, Inc · R44 · FY2016 · AT

Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease

$688,746
Marialena Mouzaki · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK

In silico Safety Pharmacology

$688,741
Colleen E Clancy · University Of California At Davis · R01 · FY2017 · HL

Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance

$688,697
John Adams · University Of South Florida · R01 · FY2019 · AI